PSMA is a type II trans-membrane glycoprotein, which is normally expressed in some epithelia (salivary and lacrimal glands, duodenum, liver and spleen) and highly expressed on the cell surface of almost 90% of prostate cancer [5]. This evidence concerns the gene FOLH1 and prostate carcinoma.